Please use this identifier to cite or link to this item:
Title: A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
Authors: Chan, Kai Siang
Ho, Bernard Chi Shern
Shelat, Vishal G.
Keywords: Science::Medicine
Issue Date: 2021
Source: Chan, K. S., Ho, B. C. S. & Shelat, V. G. (2021). A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC). Translational Gastroenterology and Hepatology, 6.
Journal: Translational Gastroenterology and Hepatology 
Abstract: Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with 5-year survival as low as 6%. It is therefore imperative to explore potential treatment avenues to improve survival in these groups of patients. Anti-estrogenic hormone therapy (AEHT) is well-tolerated and has been used in estrogen receptor (ER) subgroups of breast cancer. ER is a type of sex hormone receptor which have been reported to be expressed inconsistently in pancreatic cancer. This study aims to identify the presence of ER in PDAC specimens to guide potential use of AEHT in the management of unresectable PDAC. Methods: This is a retrospective case control study of 10 patients (5 males, 5 females) who underwent pancreatic resections for PDAC from 2011 to 2012. Sections of the post-operative specimens were prepared and sent for ER staining. Pancreatic tissue specimens that were analysed included (I) ductal epithelial cells; (II) acinar cells; (III) islet cells; (IV) intralobular stromal cells; and (V) adenocarcinoma cells. Results: Intralobular stromal cells were positively stained for ER in 7/10 (70%) of the cases, but were of weak intensity and patchy in distribution. Islet cells (<1%) stained for ER in 3/10 (30%) of the cases. Ductal epithelial cells, acinar cells and adenocarcinoma cells stained negative for ER in all of the cases. Conclusions: This pilot study did not detect the presence of ER expression in PDAC. ER expression in intralobular stromal and islet cells which was previously unreported, were noted in our study. The role of AEHT in pancreatic cancer remains uncertain and does not appear to be of value at present.
ISSN: 2415-1289
DOI: 10.21037/TGH.2020.02.16
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
Rights: © Translational Gastroenterology and Hepatology. All rights reserved. This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See:
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
5790-PB6-2311-R3.pdf1.38 MBAdobe PDFThumbnail

Citations 50

Updated on Sep 22, 2023

Web of ScienceTM
Citations 50

Updated on Sep 25, 2023

Page view(s)

Updated on Sep 23, 2023


Updated on Sep 23, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.